Cash Flow Statement

Daily Values

Growth Metrics

Income Statement

Consolidated Net Income Cost of Revenue EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Gross Profit Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Operating Expenses Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding (Weighted Average)

Others

BioLineRx (BLRX) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $2.2 billion.